| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 6.31e-06 | 4 | 21 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.58e-05 | 6 | 21 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | retinoic acid-responsive element binding | 2.21e-05 | 7 | 21 | 2 | GO:0044323 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.60e-04 | 18 | 21 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 1.60e-04 | 18 | 21 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 3.11e-04 | 25 | 21 | 2 | GO:0003707 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 4.81e-04 | 31 | 21 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.45e-04 | 33 | 21 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 5.79e-04 | 34 | 21 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 9.49e-04 | 187 | 21 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.51e-03 | 55 | 21 | 2 | GO:0042974 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 1.80e-03 | 60 | 21 | 2 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 1.86e-03 | 61 | 21 | 2 | GO:0098531 | |
| GeneOntologyMolecularFunction | calcium channel activity | 8.03e-03 | 129 | 21 | 2 | GO:0005262 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 9.09e-03 | 417 | 21 | 3 | GO:0061629 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 9.39e-03 | 140 | 21 | 2 | GO:0099094 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.09e-02 | 151 | 21 | 2 | GO:0015085 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 7.99e-06 | 37 | 22 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 9.39e-06 | 39 | 22 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 1.36e-05 | 44 | 22 | 3 | GO:0070296 | |
| GeneOntologyBiologicalProcess | positive regulation of vitamin D receptor signaling pathway | 1.62e-05 | 6 | 22 | 2 | GO:0070564 | |
| GeneOntologyBiologicalProcess | regulation of vitamin D receptor signaling pathway | 4.86e-05 | 10 | 22 | 2 | GO:0070562 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 5.94e-05 | 11 | 22 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | vitamin D receptor signaling pathway | 7.12e-05 | 12 | 22 | 2 | GO:0070561 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 9.81e-05 | 14 | 22 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in prostate gland development | 1.13e-04 | 15 | 22 | 2 | GO:0060742 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell differentiation | 1.84e-04 | 19 | 22 | 2 | GO:0055012 | |
| GeneOntologyBiologicalProcess | response to caffeine | 2.25e-04 | 21 | 22 | 2 | GO:0031000 | |
| GeneOntologyBiologicalProcess | cellular response to ATP | 2.25e-04 | 21 | 22 | 2 | GO:0071318 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin D | 2.71e-04 | 23 | 22 | 2 | GO:0071305 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 3.72e-04 | 605 | 22 | 5 | GO:0071407 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 4.85e-04 | 146 | 22 | 3 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 4.95e-04 | 147 | 22 | 3 | GO:0051283 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin | 4.96e-04 | 31 | 22 | 2 | GO:0071295 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 5.14e-04 | 149 | 22 | 3 | GO:0051282 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 5.56e-04 | 153 | 22 | 3 | GO:0051208 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 5.77e-04 | 155 | 22 | 3 | GO:0043401 | |
| GeneOntologyBiologicalProcess | reproductive structure development | 6.57e-04 | 383 | 22 | 4 | GO:0048608 | |
| GeneOntologyBiologicalProcess | reproductive system development | 6.90e-04 | 388 | 22 | 4 | GO:0061458 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 7.10e-04 | 391 | 22 | 4 | GO:0051146 | |
| GeneOntologyBiologicalProcess | maintenance of location | 7.44e-04 | 396 | 22 | 4 | GO:0051235 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 7.46e-04 | 38 | 22 | 2 | GO:0048384 | |
| GeneOntologyBiologicalProcess | response to vitamin D | 7.46e-04 | 38 | 22 | 2 | GO:0033280 | |
| GeneOntologyBiologicalProcess | muscle contraction | 7.73e-04 | 400 | 22 | 4 | GO:0006936 | |
| GeneOntologyBiologicalProcess | response to ATP | 8.27e-04 | 40 | 22 | 2 | GO:0033198 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 8.27e-04 | 40 | 22 | 2 | GO:0071312 | |
| GeneOntologyBiologicalProcess | maternal placenta development | 1.00e-03 | 44 | 22 | 2 | GO:0001893 | |
| GeneOntologyBiologicalProcess | regulation of response to nutrient levels | 1.09e-03 | 46 | 22 | 2 | GO:0032107 | |
| GeneOntologyBiologicalProcess | positive regulation of bone mineralization | 1.24e-03 | 49 | 22 | 2 | GO:0030501 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.24e-03 | 202 | 22 | 3 | GO:0141193 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | 1.24e-03 | 1194 | 22 | 6 | GO:0048609 | |
| GeneOntologyBiologicalProcess | mRNA transcription by RNA polymerase II | 1.39e-03 | 52 | 22 | 2 | GO:0042789 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | 1.48e-03 | 1235 | 22 | 6 | GO:0003006 | |
| GeneOntologyBiologicalProcess | myotube cell development | 1.50e-03 | 54 | 22 | 2 | GO:0014904 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.53e-03 | 217 | 22 | 3 | GO:0006941 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.53e-03 | 217 | 22 | 3 | GO:0097553 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient | 1.56e-03 | 55 | 22 | 2 | GO:0031670 | |
| GeneOntologyBiologicalProcess | mRNA transcription | 1.67e-03 | 57 | 22 | 2 | GO:0009299 | |
| GeneOntologyBiologicalProcess | positive regulation of biomineral tissue development | 1.85e-03 | 60 | 22 | 2 | GO:0070169 | |
| GeneOntologyBiologicalProcess | male meiotic nuclear division | 1.85e-03 | 60 | 22 | 2 | GO:0007140 | |
| GeneOntologyBiologicalProcess | prostate gland development | 1.98e-03 | 62 | 22 | 2 | GO:0030850 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 2.01e-03 | 239 | 22 | 3 | GO:0071383 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 2.13e-03 | 244 | 22 | 3 | GO:0009755 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 2.20e-03 | 531 | 22 | 4 | GO:0042692 | |
| GeneOntologyBiologicalProcess | positive regulation of ossification | 2.24e-03 | 66 | 22 | 2 | GO:0045778 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol phosphate biosynthetic process | 2.24e-03 | 66 | 22 | 2 | GO:0046854 | |
| GeneOntologyBiologicalProcess | regulation of myelination | 2.30e-03 | 67 | 22 | 2 | GO:0031641 | |
| GeneOntologyBiologicalProcess | developmental growth | 2.34e-03 | 911 | 22 | 5 | GO:0048589 | |
| GeneOntologyBiologicalProcess | organ growth | 2.44e-03 | 256 | 22 | 3 | GO:0035265 | |
| GeneOntologyBiologicalProcess | muscle system process | 2.45e-03 | 547 | 22 | 4 | GO:0003012 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 2.53e-03 | 259 | 22 | 3 | GO:0051651 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient levels | 2.61e-03 | 262 | 22 | 3 | GO:0031669 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 2.63e-03 | 558 | 22 | 4 | GO:0060537 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 2.72e-03 | 266 | 22 | 3 | GO:0019722 | |
| GeneOntologyBiologicalProcess | maternal process involved in female pregnancy | 2.73e-03 | 73 | 22 | 2 | GO:0060135 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 3.03e-03 | 77 | 22 | 2 | GO:0051289 | |
| GeneOntologyBiologicalProcess | urogenital system development | 3.18e-03 | 79 | 22 | 2 | GO:0001655 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell proliferation | 3.43e-03 | 82 | 22 | 2 | GO:0060038 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 3.65e-03 | 611 | 22 | 4 | GO:0030003 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 3.89e-03 | 622 | 22 | 4 | GO:0006873 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 3.89e-03 | 622 | 22 | 4 | GO:0098771 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 3.93e-03 | 88 | 22 | 2 | GO:0071277 | |
| GeneOntologyBiologicalProcess | regulation of bone mineralization | 4.20e-03 | 91 | 22 | 2 | GO:0030500 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 4.28e-03 | 1048 | 22 | 5 | GO:0014070 | |
| GeneOntologyCellularComponent | junctional membrane complex | 3.79e-05 | 9 | 22 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | calcium channel complex | 6.00e-05 | 73 | 22 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | myofibril | 1.73e-04 | 273 | 22 | 4 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.18e-04 | 290 | 22 | 4 | GO:0043292 | |
| GeneOntologyCellularComponent | Z disc | 5.14e-04 | 151 | 22 | 3 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 6.78e-04 | 166 | 22 | 3 | GO:0031674 | |
| GeneOntologyCellularComponent | sarcolemma | 1.00e-03 | 190 | 22 | 3 | GO:0042383 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.02e-03 | 45 | 22 | 2 | GO:0033017 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 1.06e-03 | 46 | 22 | 2 | GO:0005790 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.06e-03 | 46 | 22 | 2 | GO:0005891 | |
| GeneOntologyCellularComponent | cation channel complex | 1.84e-03 | 235 | 22 | 3 | GO:0034703 | |
| GeneOntologyCellularComponent | sarcomere | 2.17e-03 | 249 | 22 | 3 | GO:0030017 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 3.83e-03 | 88 | 22 | 2 | GO:0016529 | |
| MousePheno | abnormal lens topology | 9.12e-05 | 12 | 17 | 2 | MP:0020486 | |
| MousePheno | translucent skin | 1.45e-04 | 15 | 17 | 2 | MP:0001201 | |
| MousePheno | skeletal muscle fiber degeneration | 2.88e-04 | 21 | 17 | 2 | MP:0009412 | |
| MousePheno | decreased skeletal muscle fiber number | 2.88e-04 | 21 | 17 | 2 | MP:0009406 | |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 3.47e-04 | 23 | 17 | 2 | MP:0004088 | |
| MousePheno | decreased skeletal muscle weight | 3.78e-04 | 24 | 17 | 2 | MP:0010239 | |
| MousePheno | impaired muscle contractility | 3.82e-04 | 297 | 17 | 4 | MP:0000738 | |
| MousePheno | impaired muscle relaxation | 5.16e-04 | 28 | 17 | 2 | MP:0003157 | |
| MousePheno | abnormal skeletal muscle weight | 5.54e-04 | 29 | 17 | 2 | MP:0010237 | |
| MousePheno | skeletal muscle degeneration | 5.94e-04 | 30 | 17 | 2 | MP:0009415 | |
| MousePheno | abnormal muscle electrophysiology | 6.76e-04 | 32 | 17 | 2 | MP:0004145 | |
| MousePheno | decreased muscle weight | 7.63e-04 | 34 | 17 | 2 | MP:0004232 | |
| MousePheno | increased total tissue mass | 8.22e-04 | 364 | 17 | 4 | MP:0012323 | |
| MousePheno | increased body weight | 8.22e-04 | 364 | 17 | 4 | MP:0001260 | |
| MousePheno | decreased cardiac output | 9.04e-04 | 37 | 17 | 2 | MP:0003393 | |
| MousePheno | decreased skeletal muscle fiber diameter | 1.16e-03 | 42 | 17 | 2 | MP:0009402 | |
| MousePheno | increased variability of skeletal muscle fiber size | 1.22e-03 | 43 | 17 | 2 | MP:0009403 | |
| MousePheno | increased body size | 1.27e-03 | 409 | 17 | 4 | MP:0001264 | |
| MousePheno | abnormal muscle weight | 1.28e-03 | 44 | 17 | 2 | MP:0004233 | |
| MousePheno | impaired skeletal muscle contractility | 1.28e-03 | 44 | 17 | 2 | MP:0002841 | |
| MousePheno | abnormal muscle contractility | 1.38e-03 | 418 | 17 | 4 | MP:0005620 | |
| Domain | RyR | 3.61e-06 | 3 | 21 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 3.61e-06 | 3 | 21 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 3.61e-06 | 3 | 21 | 2 | PF06459 | |
| Domain | Ryanrecept_TM4-6 | 3.61e-06 | 3 | 21 | 2 | IPR009460 | |
| Domain | Ryan_recept | 3.61e-06 | 3 | 21 | 2 | IPR013333 | |
| Domain | RIH_assoc | 1.80e-05 | 6 | 21 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 1.80e-05 | 6 | 21 | 2 | IPR013662 | |
| Domain | RYDR_ITPR | 1.80e-05 | 6 | 21 | 2 | PF01365 | |
| Domain | RIH_dom | 1.80e-05 | 6 | 21 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.80e-05 | 6 | 21 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.80e-05 | 6 | 21 | 2 | IPR015925 | |
| Domain | Ins145_P3_rec | 1.80e-05 | 6 | 21 | 2 | PF08709 | |
| Domain | - | 1.80e-05 | 6 | 21 | 2 | 1.25.10.30 | |
| Domain | Retinoid-X_rcpt/HNF4 | 5.39e-05 | 10 | 21 | 2 | IPR000003 | |
| Domain | MIR | 5.39e-05 | 10 | 21 | 2 | PS50919 | |
| Domain | MIR | 5.39e-05 | 10 | 21 | 2 | PF02815 | |
| Domain | MIR | 5.39e-05 | 10 | 21 | 2 | SM00472 | |
| Domain | MIR_motif | 5.39e-05 | 10 | 21 | 2 | IPR016093 | |
| Domain | HEAT_REPEAT | 6.39e-05 | 70 | 21 | 3 | PS50077 | |
| Domain | HEAT_type_2 | 1.62e-04 | 17 | 21 | 2 | IPR021133 | |
| Domain | ARM-type_fold | 5.00e-04 | 339 | 21 | 4 | IPR016024 | |
| Domain | zf-C4 | 1.21e-03 | 46 | 21 | 2 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 1.21e-03 | 46 | 21 | 2 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 1.21e-03 | 46 | 21 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 1.21e-03 | 46 | 21 | 2 | IPR001723 | |
| Domain | ZnF_C4 | 1.21e-03 | 46 | 21 | 2 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 1.21e-03 | 46 | 21 | 2 | PS51030 | |
| Domain | - | 1.26e-03 | 47 | 21 | 2 | 1.10.565.10 | |
| Domain | HOLI | 1.32e-03 | 48 | 21 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 1.32e-03 | 48 | 21 | 2 | IPR000536 | |
| Domain | Hormone_recep | 1.32e-03 | 48 | 21 | 2 | PF00104 | |
| Domain | HEAT | 1.32e-03 | 48 | 21 | 2 | PF02985 | |
| Domain | - | 1.85e-03 | 57 | 21 | 2 | 3.30.50.10 | |
| Domain | HEAT | 1.92e-03 | 58 | 21 | 2 | IPR000357 | |
| Domain | Znf_NHR/GATA | 1.92e-03 | 58 | 21 | 2 | IPR013088 | |
| Domain | - | 2.98e-03 | 261 | 21 | 3 | 1.10.238.10 | |
| Domain | ARM-like | 3.28e-03 | 270 | 21 | 3 | IPR011989 | |
| Domain | EF-hand-dom_pair | 3.89e-03 | 287 | 21 | 3 | IPR011992 | |
| Domain | SPRY | 4.25e-03 | 87 | 21 | 2 | SM00449 | |
| Domain | SPRY | 4.95e-03 | 94 | 21 | 2 | PF00622 | |
| Domain | SPRY_dom | 4.95e-03 | 94 | 21 | 2 | IPR003877 | |
| Domain | B30.2/SPRY | 5.05e-03 | 95 | 21 | 2 | IPR001870 | |
| Domain | B302_SPRY | 5.05e-03 | 95 | 21 | 2 | PS50188 | |
| Domain | Ion_trans_dom | 7.19e-03 | 114 | 21 | 2 | IPR005821 | |
| Domain | Ion_trans | 7.19e-03 | 114 | 21 | 2 | PF00520 | |
| Pathway | KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION | 1.54e-05 | 5 | 18 | 2 | M49023 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS | 1.54e-05 | 5 | 18 | 2 | M29812 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE | 1.54e-05 | 5 | 18 | 2 | M29791 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE | 1.54e-05 | 5 | 18 | 2 | M29792 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 2.30e-05 | 6 | 18 | 2 | MM15663 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 2.30e-05 | 6 | 18 | 2 | M48097 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 5.51e-05 | 9 | 18 | 2 | M29809 | |
| Pathway | KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY | 5.51e-05 | 9 | 18 | 2 | M47629 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS | 5.51e-05 | 9 | 18 | 2 | M29789 | |
| Pathway | WP_VITAMIN_D_METABOLISM | 6.89e-05 | 10 | 18 | 2 | M39352 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 8.41e-05 | 11 | 18 | 2 | M47958 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 1.11e-04 | 75 | 18 | 3 | M39568 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.19e-04 | 13 | 18 | 2 | M39589 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.19e-04 | 13 | 18 | 2 | MM15622 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.60e-04 | 19 | 18 | 2 | M47760 | |
| Pathway | PID_RXR_VDR_PATHWAY | 4.91e-04 | 26 | 18 | 2 | M162 | |
| Pathway | KEGG_THYROID_CANCER | 6.13e-04 | 29 | 18 | 2 | M523 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 6.56e-04 | 30 | 18 | 2 | M207 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 9.99e-04 | 37 | 18 | 2 | M29790 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 1.05e-03 | 38 | 18 | 2 | MM15865 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 1.05e-03 | 38 | 18 | 2 | M39657 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.13e-03 | 165 | 18 | 3 | MM15026 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 1.24e-03 | 1022 | 18 | 6 | MM15436 | |
| Pathway | WP_VITAMIN_A_AND_CAROTENOID_METABOLISM | 1.35e-03 | 43 | 18 | 2 | M39554 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.35e-03 | 43 | 18 | 2 | M27443 | |
| Pathway | WP_RETINOL_METABOLISM | 1.41e-03 | 44 | 18 | 2 | MM15851 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.54e-03 | 46 | 18 | 2 | M239 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.61e-03 | 47 | 18 | 2 | M29777 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.68e-03 | 48 | 18 | 2 | MM14987 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.75e-03 | 49 | 18 | 2 | MM15186 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 2.04e-03 | 53 | 18 | 2 | M8276 | |
| Pathway | PID_AR_TF_PATHWAY | 2.04e-03 | 53 | 18 | 2 | M151 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.05e-03 | 203 | 18 | 3 | M5485 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.12e-03 | 54 | 18 | 2 | MM15202 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.12e-03 | 54 | 18 | 2 | M27460 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 2.12e-03 | 54 | 18 | 2 | M19818 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 2.24e-03 | 768 | 18 | 5 | MM14851 | |
| Pathway | WP_PPAR_SIGNALING | 3.24e-03 | 67 | 18 | 2 | M39553 | |
| Pathway | KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY | 3.24e-03 | 67 | 18 | 2 | M10462 | |
| Pathway | KEGG_PPAR_SIGNALING_PATHWAY | 3.43e-03 | 69 | 18 | 2 | M13088 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 3.73e-03 | 72 | 18 | 2 | M39738 | |
| Pathway | WP_PPAR_SIGNALING_PATHWAY | 3.84e-03 | 73 | 18 | 2 | MM15995 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 3.94e-03 | 74 | 18 | 2 | M48080 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 5.05e-03 | 84 | 18 | 2 | M3228 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 5.89e-03 | 1387 | 18 | 6 | M734 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 33246082 | ||
| Pubmed | RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. | 3.82e-07 | 2 | 22 | 2 | 7926783 | |
| Pubmed | Endogenous retinoid X receptor ligands in mouse hematopoietic cells. | 3.82e-07 | 2 | 22 | 2 | 29089448 | |
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 3.82e-07 | 2 | 22 | 2 | 15894801 | |
| Pubmed | Three retinoid X receptor gene polymorphisms in plaque psoriasis and psoriasis guttata. | 3.82e-07 | 2 | 22 | 2 | 17341859 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 9799464 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 9817784 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 12565913 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 16199515 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 9489997 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 9192302 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 24810760 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 3.82e-07 | 2 | 22 | 2 | 12640042 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 8780715 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 20798333 | ||
| Pubmed | A transcriptionally silent RXRalpha supports early embryonic morphogenesis and heart development. | 3.82e-07 | 2 | 22 | 2 | 19255444 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 22316320 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 7556644 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 14592949 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 3.82e-07 | 2 | 22 | 2 | 17118445 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 3.82e-07 | 2 | 22 | 2 | 11500519 | |
| Pubmed | Retinoid X receptors: X-ploring their (patho)physiological functions. | 1.15e-06 | 3 | 22 | 2 | 15608692 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 8034312 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 9242641 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 18403125 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 11171121 | ||
| Pubmed | Unique response pathways are established by allosteric interactions among nuclear hormone receptors. | 1.15e-06 | 3 | 22 | 2 | 7758108 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 18313230 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 22948152 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 9727070 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 7831303 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.15e-06 | 3 | 22 | 2 | 10788707 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 8631847 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 18434746 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 19188585 | ||
| Pubmed | Retinoid receptors trigger neuritogenesis in retinal degenerations. | 1.15e-06 | 3 | 22 | 2 | 21940995 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 7990953 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 25239916 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 11839661 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.15e-06 | 3 | 22 | 2 | 7621815 | |
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.15e-06 | 3 | 22 | 2 | 9204703 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 18643873 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 11159936 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 27184385 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 31680123 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 7876312 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 21881589 | ||
| Pubmed | Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. | 1.15e-06 | 3 | 22 | 2 | 1312497 | |
| Pubmed | Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. | 1.15e-06 | 3 | 22 | 2 | 19897601 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 18375961 | ||
| Pubmed | Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies. | 1.15e-06 | 3 | 22 | 2 | 7980510 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 18217139 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 10049761 | ||
| Pubmed | Immunohistochemical detection of the retinoid X receptors alpha, beta, and gamma in human prostate. | 1.15e-06 | 3 | 22 | 2 | 12514092 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 11053444 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.15e-06 | 3 | 22 | 2 | 10473538 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 7959768 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 8799145 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.15e-06 | 3 | 22 | 2 | 12213830 | |
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.15e-06 | 3 | 22 | 2 | 4600883 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 7635066 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 22100703 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 10594021 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 9384575 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 8670810 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 18206662 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 9804293 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 1310259 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 9607712 | ||
| Pubmed | Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. | 2.29e-06 | 4 | 22 | 2 | 7481822 | |
| Pubmed | Retinoic acid biosynthetic activity and retinoid receptors in the olfactory mucosa of adult mice. | 2.29e-06 | 4 | 22 | 2 | 10079186 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 8524212 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 32246014 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 7967725 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 26355550 | ||
| Pubmed | Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. | 2.29e-06 | 4 | 22 | 2 | 19198614 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 10611353 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 12549917 | ||
| Pubmed | Retinoids activate RXR/CAR-mediated pathway and induce CYP3A. | 2.29e-06 | 4 | 22 | 2 | 19686701 | |
| Pubmed | Retinoid X receptors are essential for early mouse development and placentogenesis. | 2.29e-06 | 4 | 22 | 2 | 9892670 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 9348290 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 23482488 | ||
| Pubmed | iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin. | 2.29e-06 | 4 | 22 | 2 | 32693782 | |
| Pubmed | Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling. | 2.29e-06 | 4 | 22 | 2 | 25574839 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 2.29e-06 | 4 | 22 | 2 | 23413940 | |
| Pubmed | Retinoic X receptor subtypes exert differential effects on the regulation of Trh transcription. | 2.29e-06 | 4 | 22 | 2 | 23896434 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 18488020 | ||
| Pubmed | Retinoic acid signaling is necessary for the development of the organ of Corti. | 3.82e-06 | 5 | 22 | 2 | 10452855 | |
| Pubmed | A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. | 3.82e-06 | 5 | 22 | 2 | 7705655 | |
| Pubmed | Developmental expression of murine retinoid X receptor (RXR) genes. | 3.82e-06 | 5 | 22 | 2 | 8199055 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 9053308 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 3.82e-06 | 5 | 22 | 2 | 19011160 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 16880407 | ||
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 1331778 | ||
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 23918386 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 22205725 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 19549818 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 19009018 | ||
| Pubmed | The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. | 5.72e-06 | 6 | 22 | 2 | 9806918 | |
| Pubmed | Systematic immunolocalization of retinoid receptors in developing and adult mouse eyes. | 5.72e-06 | 6 | 22 | 2 | 11328745 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.43e-06 | 3 | 13 | 2 | 287 | |
| GeneFamily | Nuclear hormone receptors | 5.51e-04 | 49 | 13 | 2 | 71 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 8.91e-07 | 2 | 22 | 2 | ctd:C005147 | |
| Drug | isotetrandrine | 2.13e-06 | 97 | 22 | 4 | CID000005422 | |
| Drug | 2-hydroxyheptanoic acid | 2.67e-06 | 3 | 22 | 2 | CID002750949 | |
| Drug | flubendiamide | 2.67e-06 | 3 | 22 | 2 | CID011193251 | |
| Drug | Bexarotene | 2.67e-06 | 3 | 22 | 2 | DB00307 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 2.67e-06 | 3 | 22 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 2.67e-06 | 3 | 22 | 2 | CID000127713 | |
| Drug | 2-hydroxycarbazole | 2.67e-06 | 3 | 22 | 2 | CID000093551 | |
| Drug | aminodantrolene | 2.67e-06 | 3 | 22 | 2 | CID009570289 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 2.67e-06 | 3 | 22 | 2 | CID000080262 | |
| Drug | 2-hydroxyphytanic acid | 2.67e-06 | 3 | 22 | 2 | ctd:C002585 | |
| Drug | cis-diammineplatinum(II | 2.67e-06 | 3 | 22 | 2 | CID000159790 | |
| Drug | AC1O5SBP | 2.67e-06 | 3 | 22 | 2 | CID006439746 | |
| Drug | AC1L3LFV | 4.19e-06 | 33 | 22 | 3 | CID000091134 | |
| Drug | A-30 | 5.34e-06 | 4 | 22 | 2 | CID003028528 | |
| Drug | Bastadin 10 | 5.34e-06 | 4 | 22 | 2 | CID009589366 | |
| Drug | SC 38249 | 5.34e-06 | 4 | 22 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 5.34e-06 | 4 | 22 | 2 | CID000035682 | |
| Drug | PCB74 | 5.34e-06 | 4 | 22 | 2 | CID000036218 | |
| Drug | AGN 190727 | 5.34e-06 | 4 | 22 | 2 | CID006439768 | |
| Drug | 148504-47-6 | 5.34e-06 | 4 | 22 | 2 | CID006444275 | |
| Drug | vitamin D3 analog | 8.15e-06 | 41 | 22 | 3 | CID006438384 | |
| Drug | 7-methoxycitronellal | 8.90e-06 | 5 | 22 | 2 | CID000019223 | |
| Drug | 13,14-dihydroretinol | 8.90e-06 | 5 | 22 | 2 | CID000446798 | |
| Drug | 7-methoxycitronellic acid | 8.90e-06 | 5 | 22 | 2 | CID000171516 | |
| Drug | Alitretinoin | 1.33e-05 | 6 | 22 | 2 | DB00523 | |
| Drug | NSC-635471 | 1.33e-05 | 6 | 22 | 2 | CID000366744 | |
| Drug | Methoprene | 1.33e-05 | 6 | 22 | 2 | ctd:D008726 | |
| Drug | AC1O528X | 1.33e-05 | 6 | 22 | 2 | CID006475857 | |
| Drug | Adapalene | 1.33e-05 | 6 | 22 | 2 | DB00210 | |
| Drug | CTMs | 1.33e-05 | 6 | 22 | 2 | CID000192530 | |
| Drug | Etretinate | 1.33e-05 | 6 | 22 | 2 | DB00926 | |
| Drug | NSC114784 | 1.33e-05 | 6 | 22 | 2 | CID000419425 | |
| Drug | NSC692750 | 1.33e-05 | 6 | 22 | 2 | CID000078910 | |
| Drug | MBED | 1.33e-05 | 6 | 22 | 2 | CID000129958 | |
| Drug | triphenyltin hydroxide | 1.33e-05 | 6 | 22 | 2 | ctd:C007567 | |
| Drug | chloro-m-cresol | 1.33e-05 | 6 | 22 | 2 | CID000012008 | |
| Drug | Azumoleno | 1.87e-05 | 7 | 22 | 2 | CID000056259 | |
| Drug | Acitretin | 1.87e-05 | 7 | 22 | 2 | DB00459 | |
| Drug | AGN 191659 | 1.87e-05 | 7 | 22 | 2 | CID006366726 | |
| Drug | mag-indo-1 | 1.87e-05 | 7 | 22 | 2 | CID000131881 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.87e-05 | 7 | 22 | 2 | CID009547999 | |
| Drug | AGN 190121 | 1.87e-05 | 7 | 22 | 2 | CID006441236 | |
| Drug | CHEBI:564108 | 1.87e-05 | 7 | 22 | 2 | CID006400637 | |
| Drug | Br2BAPTA | 1.87e-05 | 7 | 22 | 2 | CID003081001 | |
| Drug | BAPNA | 2.21e-05 | 57 | 22 | 3 | CID000013494 | |
| Drug | HX 600 | 2.49e-05 | 8 | 22 | 2 | ctd:C104181 | |
| Drug | TTNN | 2.49e-05 | 8 | 22 | 2 | CID000135754 | |
| Drug | AC1O5JP6 | 2.49e-05 | 8 | 22 | 2 | CID006435379 | |
| Drug | succinylcholine | 3.14e-05 | 64 | 22 | 3 | CID000005314 | |
| Drug | lactosyl lysosphingolipid | 3.20e-05 | 9 | 22 | 2 | CID006439268 | |
| Drug | FLA 365 | 3.20e-05 | 9 | 22 | 2 | CID000072776 | |
| Drug | creatine | 3.25e-05 | 193 | 22 | 4 | CID000000586 | |
| Drug | AC1N38XE | 3.99e-05 | 10 | 22 | 2 | CID004060965 | |
| Drug | HX 630 | 3.99e-05 | 10 | 22 | 2 | ctd:C422175 | |
| Drug | PCB 95 | 3.99e-05 | 10 | 22 | 2 | CID000038012 | |
| Drug | diazepinylbenzoic acid | 3.99e-05 | 10 | 22 | 2 | ctd:C438269 | |
| Drug | R 478 | 4.88e-05 | 11 | 22 | 2 | CID000084223 | |
| Drug | AGN 191701 | 4.88e-05 | 11 | 22 | 2 | CID006438168 | |
| Drug | 8-amino-cADPR | 4.88e-05 | 11 | 22 | 2 | CID003081323 | |
| Drug | PCB 66 | 4.88e-05 | 11 | 22 | 2 | CID000036185 | |
| Drug | UVI 3003 | 4.88e-05 | 11 | 22 | 2 | ctd:C525131 | |
| Drug | Musk T | 4.88e-05 | 11 | 22 | 2 | CID000061014 | |
| Drug | di-n-propylphthalate | 5.85e-05 | 12 | 22 | 2 | ctd:C106479 | |
| Drug | 2-amino-2-methyl-1-propanol | 5.85e-05 | 12 | 22 | 2 | CID000011807 | |
| Drug | Ryanodine | 5.85e-05 | 12 | 22 | 2 | ctd:D012433 | |
| Drug | NSC46155 | 5.85e-05 | 12 | 22 | 2 | CID000457869 | |
| Drug | tazarotenic acid | 6.91e-05 | 13 | 22 | 2 | CID000147525 | |
| Drug | GW2331 | 6.91e-05 | 13 | 22 | 2 | CID000657048 | |
| Drug | Cd2665 | 6.91e-05 | 13 | 22 | 2 | CID000216241 | |
| Drug | NSC299933 | 6.91e-05 | 13 | 22 | 2 | CID000431902 | |
| Drug | europium | 7.87e-05 | 87 | 22 | 3 | CID000023981 | |
| Drug | bimoclomol | 8.05e-05 | 14 | 22 | 2 | CID009576891 | |
| Drug | Sulfonamides | 8.05e-05 | 14 | 22 | 2 | ctd:D013449 | |
| Drug | cysteamine hydrochloride | 8.05e-05 | 14 | 22 | 2 | CID000009082 | |
| Drug | AC1L1DMQ | 8.05e-05 | 14 | 22 | 2 | CID000002418 | |
| Drug | NP-EGTA | 8.05e-05 | 14 | 22 | 2 | CID000183793 | |
| Drug | FPL 64176 | 9.29e-05 | 15 | 22 | 2 | CID000003423 | |
| Drug | Gvapspat amide | 9.29e-05 | 15 | 22 | 2 | CID000125015 | |
| Drug | TAT-59 | 1.06e-04 | 16 | 22 | 2 | CID003034829 | |
| Drug | DM-nitrophen | 1.06e-04 | 16 | 22 | 2 | CID000003083 | |
| Drug | TMPone | 1.06e-04 | 16 | 22 | 2 | CID000013220 | |
| Drug | strontium chromate | 1.16e-04 | 99 | 22 | 3 | CID000024599 | |
| Drug | kazinol B | 1.20e-04 | 17 | 22 | 2 | CID000480869 | |
| Drug | phthalic acid | 1.20e-04 | 17 | 22 | 2 | ctd:C032279 | |
| Drug | vitamin D3 | 1.32e-04 | 277 | 22 | 4 | CID000002735 | |
| Drug | NSC635470 | 1.35e-04 | 18 | 22 | 2 | CID000003664 | |
| Drug | HX600 | 1.35e-04 | 18 | 22 | 2 | CID000128016 | |
| Drug | methylcoumarin | 1.35e-04 | 18 | 22 | 2 | CID000007092 | |
| Drug | androst-2-en-3-ol | 1.35e-04 | 18 | 22 | 2 | CID000166036 | |
| Drug | E-guggulsterone | 1.50e-04 | 108 | 22 | 3 | CID006439929 | |
| Drug | AC1L380G | 1.51e-04 | 19 | 22 | 2 | CID000084698 | |
| Drug | AC1MW7VF | 1.51e-04 | 19 | 22 | 2 | CID000414699 | |
| Drug | thiopental | 1.67e-04 | 112 | 22 | 3 | CID003000715 | |
| Drug | cyanyl | 1.68e-04 | 20 | 22 | 2 | CID005359238 | |
| Drug | diheptyl phthalate | 1.85e-04 | 21 | 22 | 2 | ctd:C089799 | |
| Drug | indo-1/AM | 1.85e-04 | 21 | 22 | 2 | CID000123918 | |
| Drug | AC1NBUB1 | 1.85e-04 | 21 | 22 | 2 | CID004473866 | |
| Drug | AC1L1CR9 | 1.85e-04 | 21 | 22 | 2 | CID000002023 | |
| Drug | TCNB | 1.99e-04 | 119 | 22 | 3 | CID000008330 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.31e-06 | 3 | 20 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.31e-06 | 3 | 20 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.98e-04 | 195 | 20 | 3 | DOID:1574 (implicated_via_orthology) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.34e-03 | 80 | 20 | 2 | DOID:6432 (biomarker_via_orthology) | |
| Disease | influenza A (H1N1) | 1.58e-03 | 87 | 20 | 2 | EFO_1001488 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLPLMELMENEALEI | 146 | Q9NTU4 | |
| MILDEVKMHLPALET | 1476 | P11532 | |
| LLVEPEEVVEMSHMP | 431 | O75943 | |
| IEIMPELADSLVPME | 516 | Q9NV88 | |
| APLEELMMEGDLLEV | 1381 | Q9BY66 | |
| LMELHMVLPAPDTDE | 1106 | Q92616 | |
| LHSIMALLPEPKEED | 871 | Q8NDA8 | |
| PLMLSSHLEEMVDPE | 446 | P48551 | |
| EIHRDPTLDPSLMEM | 296 | P09923 | |
| DLDMELSLMQPLVPE | 411 | Q9ULV5 | |
| AEMEELLLPTPLEMH | 926 | Q9C0E4 | |
| PIDTFLMEMLEAPHQ | 446 | P19793 | |
| EPLTMMALHIPEENR | 1631 | P21817 | |
| ELSHVQIPVMLMPDD | 51 | P48426 | |
| NLPPDHLVEVREMMS | 211 | Q9BXB4 | |
| IPMDPEHVELVKRTM | 131 | Q16626 | |
| EPVLIESLKDMMDPV | 446 | Q6NUJ1 | |
| PLHVMKAVLEELMEA | 2276 | Q96Q15 | |
| TPIDTFLMEMLEAPH | 516 | P28702 | |
| PLLLVHDMSEEMTIP | 471 | Q9NQ89 | |
| MPEEMDKPLISLHLV | 1 | Q658P3 | |
| LEPLQMMALHIPEEN | 1526 | Q15413 | |
| LLEAVMEILHLDMPL | 321 | Q8IYF3 |